HK1131833A1 - Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis - Google Patents

Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis

Info

Publication number
HK1131833A1
HK1131833A1 HK09110977.7A HK09110977A HK1131833A1 HK 1131833 A1 HK1131833 A1 HK 1131833A1 HK 09110977 A HK09110977 A HK 09110977A HK 1131833 A1 HK1131833 A1 HK 1131833A1
Authority
HK
Hong Kong
Prior art keywords
immunosuppression
diagnosis
microarray analysis
metastatic melanoma
blood leukocyte
Prior art date
Application number
HK09110977.7A
Other languages
English (en)
Inventor
Anna Karolina Palucka
Jacques F Banchereau
Damien Chaussabel
Original Assignee
Baylor Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Res Inst filed Critical Baylor Res Inst
Publication of HK1131833A1 publication Critical patent/HK1131833A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Data Mining & Analysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK09110977.7A 2006-11-03 2009-11-24 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis HK1131833A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85640606P 2006-11-03 2006-11-03
PCT/US2007/083555 WO2008100352A2 (fr) 2006-11-03 2007-11-03 Diagnostic de melanome metastatique et surveillance d'indicateurs d'immunosuppression par analyse de microreseaux de leucocytes sanguins

Publications (1)

Publication Number Publication Date
HK1131833A1 true HK1131833A1 (en) 2010-02-05

Family

ID=39690661

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110977.7A HK1131833A1 (en) 2006-11-03 2009-11-24 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis

Country Status (12)

Country Link
US (1) US20100076691A1 (fr)
EP (4) EP2570951A1 (fr)
JP (1) JP2010508826A (fr)
KR (1) KR20090078365A (fr)
CN (1) CN101601042A (fr)
AU (1) AU2007347118B2 (fr)
CA (1) CA2704288A1 (fr)
HK (1) HK1131833A1 (fr)
IL (1) IL198360A0 (fr)
NZ (3) NZ588574A (fr)
WO (1) WO2008100352A2 (fr)
ZA (1) ZA200903018B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2010021696A1 (fr) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Procédés et compositions pour déterminer un phénotype tolérant à une greffe chez un sujet
WO2010083121A1 (fr) * 2009-01-15 2010-07-22 The Board Of Trustees Of The Leland Stanford Junior University Panel de biomarqueurs pour le diagnostic et la prédiction d'un rejet de greffon
EP3185013B1 (fr) 2009-12-02 2019-10-09 The Board of Trustees of the Leland Stanford Junior University Biomarqueurs pour déterminer un xénotype tolérant à l'allogreffe
US9410205B2 (en) 2010-02-18 2016-08-09 New York University Methods for predicting survival in metastatic melanoma patients
US9535075B2 (en) 2010-03-25 2017-01-03 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
TWI539158B (zh) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
EP2643477A2 (fr) * 2010-11-26 2013-10-02 OncoLab Diagnostics GmbH Ensemble de marqueurs
US9234245B2 (en) * 2011-01-18 2016-01-12 Everist Genomics, Inc. Prognostic signature for colorectal cancer recurrence
WO2012154935A1 (fr) * 2011-05-12 2012-11-15 Eisai R&D Management Co., Ltd. Biomarqueurs prédictifs d'une réactivité ou d'une absence de réactivité à un traitement au lenvatinib ou à son sel pharmaceutiquement acceptable
CN102944539B (zh) * 2012-09-24 2015-02-25 杭州师范大学 基于量子点共振能量转移的mgmt活性检测试剂盒及方法
EP2971156B1 (fr) 2013-03-15 2020-07-15 Myriad Genetics, Inc. Gènes et signatures géniques pour le diagnostic et le traitement du mélanome
JP6496899B2 (ja) * 2014-07-01 2019-04-10 公立大学法人福島県立医科大学 浸潤性髄膜腫判別用試薬、及びその判別方法
AU2015284460B2 (en) 2014-07-02 2021-10-07 Myriad Mypath, Llc Genes and gene signatures for diagnosis and treatment of melanoma
CN104774252B (zh) * 2015-04-03 2018-02-06 西南大学 特异调控单宁合成的转录因子PtoMYB115及其用途
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
BR112019024481A2 (pt) * 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma
US12089930B2 (en) 2018-03-05 2024-09-17 Marquette University Method and apparatus for non-invasive hemoglobin level prediction
AT521641B1 (de) * 2018-09-12 2020-07-15 Fianostics Gmbh Verfahren zur Diagnose von Lebererkrankungen
SG11202106398WA (en) * 2018-11-04 2021-07-29 Pfs Genomics Inc Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy
KR102247432B1 (ko) 2019-01-21 2021-05-03 주식회사 에스씨엘헬스케어 암 진단용 바이오 마커 조성물 및 이의 용도
IT201900023946A1 (it) * 2019-12-13 2021-06-13 Complexdata S R L Metodo per determinare una prognosi di sopravvivenza a lungo termine di pazienti di cancro al seno, sulla base di algoritmi che modellizzano reti biologiche
CN111487399B (zh) * 2020-03-26 2021-09-17 湖南师范大学 一种蛋白分子标记在鱼类生殖细胞发育研究中的应用
CN113278630B (zh) * 2021-05-26 2022-02-15 安徽农业大学 一种改良桑树白藜芦醇生物合成的转录因子基因MaMYB14及其应用
WO2023023125A1 (fr) * 2021-08-17 2023-02-23 Predigen, Inc. Procédés de caractérisation d'infections et procédés de développement de tests correspondants

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5677195A (en) 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
JP2001521753A (ja) 1997-10-31 2001-11-13 アフィメトリックス インコーポレイテッド 成人臓器及び胎児臓器中の発現プロフィール
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20050222029A1 (en) * 2001-01-04 2005-10-06 Myriad Genetics, Incorporated Compositions and methods for treating diseases
US6955788B2 (en) 2001-09-07 2005-10-18 Affymetrix, Inc. Apparatus and method for aligning microarray printing head
WO2005074540A2 (fr) * 2004-01-30 2005-08-18 University Of Pennsylvania Nouveaux predicteurs de rejet de transplantation determine par le profilage de l'expression genique sanguine peripherique

Also Published As

Publication number Publication date
NZ576428A (en) 2012-04-27
US20100076691A1 (en) 2010-03-25
NZ598954A (en) 2012-10-26
EP2080140A2 (fr) 2009-07-22
JP2010508826A (ja) 2010-03-25
CA2704288A1 (fr) 2008-08-21
EP2506172A1 (fr) 2012-10-03
EP2579174A1 (fr) 2013-04-10
KR20090078365A (ko) 2009-07-17
EP2080140B1 (fr) 2013-04-24
WO2008100352A3 (fr) 2008-12-11
NZ588574A (en) 2012-07-27
WO2008100352A2 (fr) 2008-08-21
EP2570951A1 (fr) 2013-03-20
AU2007347118A1 (en) 2008-08-21
EP2080140A4 (fr) 2011-08-10
ZA200903018B (en) 2010-03-31
IL198360A0 (en) 2010-02-17
AU2007347118B2 (en) 2012-11-01
CN101601042A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
IL198360A0 (en) Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
EP1968610A4 (fr) Diagnostic, pronostic et suivi de la progression du lupus erythemateux systemique par analyse de microreseaux de leucocytes sanguins
EP2024745A4 (fr) Dosages biologiques pour le diagnostic et l'evaluation d'options de traitement de la maladie de fabry
IL187859A0 (en) Diagnosis and prognosis of diabetes
EP1942801A4 (fr) Dispositif de mesure d'analytes et son procede d'utilisation
EP2166928A4 (fr) Dispositif de surveillance médicale
EP2118654A4 (fr) Essai diagnostique pour la detection d'une molecule ou d'un medicament dans du sang entier
EP1968648A4 (fr) Systeme diagnostic pour la detection et le diagnostic du cancer de la peau
EP1937150A4 (fr) Sonde de diagnostic ultrasons et système de diagnostic ultrasons l'utilisant
EP2153777A4 (fr) Sonde ultrasonore et dispositif de diagnostic par ultrasons
EP2182848A4 (fr) Dispositif de contrôle d'analyte et procédés d'utilisation
PL2064993T3 (pl) Czujnik krwi i przyrząd do badania krwi zawierający ten czujnik
ZA201000095B (en) Multiple analysis of blood samples
EP1761165A4 (fr) Dispositif portable de surveillance de signaux electrocardiographiques et de signes de circulation sanguine
EP1828768A4 (fr) Systemes et procedes permettant d'identifier des indicateurs diagnostiques
EP1988824A4 (fr) Applications cliniques de l'analyse de sto2
IL185477A0 (en) Diagnostic methods and systems based on urine analysis
EP1973462A4 (fr) Systemes et procedes de mesure non invasive du volume des larmes
HK1135886A1 (en) Monitoring system and probe
GB0616376D0 (en) Raman analysis of tissue
EP1735115A4 (fr) Laveuse a pression dotee d'indicateurs de diagnostic
EP1955233A4 (fr) Procedes et systemes de suivi d'episodes cliniques d'un patient
GB2450241B (en) Systems and methods for health monitoring of complex systems
ZA201102086B (en) Measuring and monitoring mental capacity
EP2260107A4 (fr) Analyses permettant de diagnostiquer et d évaluer des options de traitement pour la maladie de pompe

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171103